Marimed (OTCMKTS:MRMD) Issues Earnings Results

Marimed (OTCMKTS:MRMD) issued its quarterly earnings data on Monday. The company reported $0.02 EPS for the quarter, Bloomberg Earnings reports. The firm had revenue of $25.67 million during the quarter.

OTCMKTS MRMD traded down $0.02 on Tuesday, reaching $1.65. The stock had a trading volume of 41,042 shares, compared to its average volume of 340,069. The stock’s fifty day moving average is $1.74. Marimed has a 1-year low of $1.21 and a 1-year high of $5.80.

About Marimed

MariMed Inc provides consulting services for the design, development, operation, funding, and optimization of medical cannabis cultivation, production, and dispensary facilities. The company also develops and manages facilities for the cultivation, production, and dispensing of legal cannabis and cannabis-infused products under the Kalm Fusion brand name.

See Also: What is channel trading?

Earnings History for Marimed (OTCMKTS:MRMD)

Receive News & Ratings for Marimed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marimed and related companies with's FREE daily email newsletter.